← Back

Doctorglasses Chain Co Ltd

Doctorglasses Chain Co., Ltd. is a Chinese eyewear retailer. It offers optical and smart glasses, sunglasses, reading glasses, contact lenses, care solutions, and eye health accessories. The company also provides optometry, frame selection, fitting and adjustment, and after-sales services. Its products are sold through store brands including doctor glasses, President Optical, Boojing, zèle, and Concrete, as well as e-commerce and franchise channels. Founded in 1993, it is headquartered in Shenzhen, China.

Country
Price · split & dividend adjusted
News & notes moving 300622.CS
300622.CS

Doctor Glasses loses final appeal in DOCTOR trademark cancellation case, says prior-use rights allow continued use

Doctor Glasses Chain Co., Ltd. announced on September 11 that it received an administrative judgment from the Beijing High People's Court, which issued a final ruling in the administrative dispute over the cancellation review of the DOCTOR trademark, registration number 1091685, brought by the company against the China National Intellectual Property Administration and a third party, Mo X Hong. The court rejected the appeal and upheld the original judgment. The case originated in December 2023, when the third party applied to cancel the company's trademark on the grounds that it had not been used for three consecutive years. Both the China National Intellectual Property Administration and the first-instance court ruled to cancel the trademark's registration for the services under review. The company appealed, and this final judgment upheld the original decision. The company stated that the trademark was applied for in 1996 and has been in use since then. Under the current Trademark Law, the company enjoys prior-use rights, and after the judgment it can continue to use the trademark normally within its existing store network. It would be difficult for others to register the trademark for similar goods or services or to claim that the company is infringing. The company's own-brand lenses and frames do not use this trademark, and this judgment will not have a material adverse impact on the company's production and operations.
Jiemian·8dRead more →
300622.CS2

Doctor Glasses' 2026 Interim Report Shows Net Profit of 83.0393 Million Yuan

Doctor Glasses released its 2026 interim report, with total operating revenue of 747 million yuan and net profit attributable to the parent company of 83.0393 million yuan. Net cash inflow from operating activities was 197 million yuan, the asset-liability ratio was 48.11%, the gross margin was 56.32%, and diluted earnings per share was 0.26 yuan. The company had 40,000 shareholders, and the top ten shareholders held 43.84% of the total share capital.
Jiemian·22dRead more →
300622.CS

Doctor Glasses Plans Cash Dividend of 1.6 Yuan per 10 Shares

Doctor Glasses announced on August 27 that it plans to distribute a cash dividend of 1.6 yuan, tax included, for every 10 shares to all shareholders, with an estimated total payout of 51.04 million yuan. In the first half of 2026, the company achieved revenue of 747 million yuan and net profit attributable to the parent of 83.04 million yuan.
财中社·23dRead more →
300622.CS

Doctor Glasses Plans to Spend 20 Million Yuan to Acquire 5.97% Stake in Partnership

Doctor Glasses plans to spend 20 million yuan to acquire a 5.97 percent stake in Anhui Kunshan Luoman Xinchuang Venture Capital Partnership. The company recently signed limited partnership fund share transfer agreements with Beijing Kunshan and Anhui Ancheng, respectively, intending to acquire the partnership shares held by each of them, with a total subscribed capital contribution of 20 million yuan, accounting for 5.97 percent of the partnership's total subscribed capital. In the first quarter of 2026, Doctor Glasses achieved revenue of 353 million yuan and net profit attributable to the parent company of 39.91 million yuan.
财中社·50dRead more →